BIGMAR, Inc. Discusses Restructuring Convertible Debt; Receives Compliance Notice From NASDAQ.JOHNSTOWN, Ohio--(BUSINESS WIRE)--Dec. 18, 1998--BIGMAR, INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic. Antonym: dec. . (Nasdaq SmallCap Market:BGMR/Boston Stock Exchange:BGM) announced today that it is negotiating the restructure of its convertible debt with Gottard Bank. The contemplated restructuring restructuring - The transformation from one representation form to another at the same relative abstraction level, while preserving the subject system's external behaviour (functionality and semantics). will reduce the current interest rate from 8% to 4% and possibly increase the Bank's equity position in Bigmar. The Company also announced that it received a notice from The Nasdaq Stock Market Nasdaq stock market The first electronic stock market listing over 5000 companies. The Nasdaq stock market comprises two separate markets, namely the Nasdaq National Market, which trades large, active securities and the Nasdaq Smallcap Market that trades emerging growth companies. , Inc. ("NASDAQ") on December 15, 1998, that it has been found to be in complete compliance with all requirements for continued listing on The Nasdaq SmallCap Market(SM). BIGMAR, Inc.'s strategy is to supply world markets with a full line of high-quality, affordably priced pharmaceutical products focusing on oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors. on·col·o·gy n. . With distribution rights to more than 20 generic pharmaceutical products, the Company intends to manufacture, in its state-of-the-art facilities in Switzerland, and market, through pharmaceutical company partners in Europe and the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , off-patent generic oncology drugs and additional drugs as their patents expire. Forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. involve known and unknown risks, uncertainties and other factors as detailed in the Company's SEC reports and filings, which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied in such forward-looking statements. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion